Innopsys, Inc.

Chicago, IL

UEI
ZHBNA5DU8K27
CAGE
73PL7
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Foreign Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
233 S Wacker Dr Suite 4400, Chicago, IL 60606, USA
Website
innopsys.com
Founded
1999
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $95,002
FY2024 $0
FY2023 $51,391

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Innopsys, Inc. is a for-profit corporate entity based in Chicago, Illinois, specializing in biomedical imaging equipment and software solutions. The company is registered in SAM.gov and focuses on providing advanced scientific and research instrumentation, particularly in the life sciences sector. Their primary product line appears to center around high-precision scanning systems like the InnoScan series, which are used in research laboratories and scientific institutions for advanced imaging and analysis.

The federal contract awards reveal that Innopsys, Inc. predominantly serves federal research agencies through purchase order contracts, with significant engagement from the Centers for Disease Control and Prevention (CDC), National Institute of Allergy and Infectious Diseases, and the U.S. Department of Agriculture's Agricultural Research Service. Their contract awards, ranging from $9,894 to $85,108, have involved providing specialized laboratory equipment such as fluorescence confocal scanners, microarray scanner systems, and related warranties and maintenance services. Many of these contracts were awarded under small business set-aside designations, and several were specifically tied to COVID-19 research initiatives. The company's equipment has supported critical research programs, with contracts focused on delivering InnoScan 710 AutoLoader systems, extending equipment warranties, and supplying biomedical research instrumentation to support public health and scientific research efforts.

Quick answers

Is Innopsys, Inc. registered in SAM.gov?

Yes. Innopsys, Inc.'s SAM.gov registration is active through September 30, 2027.

How much has Innopsys, Inc. received in federal contracts?

Federal contracts obligated $95,002 to Innopsys, Inc. in fiscal year 2025 and $146,393 in fiscal years 2023 through 2027.

What is Innopsys, Inc.'s most recent federal award?

Innopsys, Inc.'s most recent federal contract award is Scanner innoscan 710 autoloader (1232SA25P0236), from Central Program Planning Coordination and Support (ARS), on September 18, 2025.

On GovTribe

See Innopsys, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors